查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1609542

骨关节炎治疗市场规模、份额、趋势分析报告：按药物类型、解剖结构、给药途径、销售销售管道、最终用途、地区和细分市场预测，2025-2030

Osteoarthritis Therapeutics Market Size, Share & Trends Analysis Report By Drug Type, By Anatomy, By Route Of Administration, By Sales Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

骨关节炎治疗市场的成长与趋势

Grand View Research, Inc.最新报告显示，预计到2030年，全球骨关节炎（OA）治疗市场规模将达到135.7亿美元，2025年至2030年复合年增长率为6.89%。

骨关节炎治疗市场正在不断增长，特别是由于老年社会中骨关节炎病例的增加。光在美国就有超过 3,250 万人患有 OA，对有效治疗的需求不断增长。持续的研究和开发重点是创造新的治疗方法，特别是了解 OA 疾病并开发解决方案来应对其挑战。

由于其緻密的组织结构，治疗骨关节炎很困难，但随着关节内给药等新型药物的采用，标靶药物传递的发展正在加速。研发部门正在积极探索缓解疾病药物和生物适应性载体，以促进骨关节炎创新治疗方法的开发。 OrthoTrophix, Inc. 在 BIO2022 上公布了 TPX-100 治疗膝骨关节炎的临床资料和註册计划，市场相关人员正在采取倡议为市场扩张做出贡献。

此外，主要製药公司和研究机构正在做出重大努力，特别是在缓解疾病治疗方法的研究和开发领域。例如，Bioscenic 在 2024 年 OARSI 世界大会上公布的 3 期资料证明了 JTA-004 在治疗严重发炎性膝骨关节炎方面的功效。事后分析得出结论，JTA-004 安全有效，并为这种特定的病理亚型提供有针对性的疼痛管理。药物输送和缓解疾病药物方面的这些进展已通过学术会议演讲和有利的测试结果得到证明，并有助于扩大骨关节炎新疗法的市场。

此外，由于双磷酸盐和 Synvisc-ONE 注射剂等个人化治疗的采用，OA 市场正在经历显着成长。此外，製药公司和研究机构正在积极致力于开发针对 OA 的个人化和基于细胞的治疗方法。 2023 年 12 月，哥伦比亚大学的研究人员在成年小鼠干细胞中取得了突破性发现，可以维持关节软骨健康。干细胞的丧失会导致老龄化和损伤而导致骨关节炎的发生。

透过投资这一领域，公司可以满足不断变化的需求并获得竞争优势。透过主导创新药物开发，公司确立了自己的领跑者地位并巩固了其市场地位。个人化骨关节炎治疗的出现和细胞治疗方法的进步是市场扩张的关键因素，使公司成为该领域的领导者。

骨关节炎治疗市场报告亮点

  • 按药物类型划分，关节内粘稠补充疗法药物在2024 年占据最大份额，为37.06%，并且由于其在治疗OA 症状方面的采用和有效性，预计在预测期内将以最快的复合年增长率增长。
  • 从解剖结构来看，膝骨关节炎（KOA）细分市场在2024年将占据压倒性的份额，达到42.07%。膝骨关节炎（KOA）是全球最常见的慢性关节疾病，其特征是高致残率和发病率。
  • 从给药途径来看，肠胃外给药将在 2024 年占据主要份额，因为它具有特定治疗的功效、更好的药物动力学和动态、易于给药以及在预测期内更高的预期成长率，预计将以复合年增长率增长。
  • 2024年按销售管道分類的骨关节炎治疗细分市场中，组合药物预计将保持主导地位。
  • 依最终用途划分，2024年医院药局领域将占据压倒性份额，达47.50%。
  • 北美骨关节炎治疗市场主导全球产业，2024年占37.31%。由于多种因素，包括肥胖率高和政府的支持措施，北美市场仍然占据主导地位。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章骨关节炎治疗市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 骨关节炎治疗市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 价格分析

第四章骨关节炎治疗市场：药物类型、估计和趋势分析

  • 细分仪表板
  • 按药物类型分類的全球骨关节炎治疗市场前景
  • 2018-2030年全球骨关节炎治疗市场规模及趋势分析（依药物类型）
  • 关节内粘稠补充疗法剂
  • 非类固醇消炎剂
    • 止痛药
    • 皮质类固醇
    • 其他的

第五章骨关节炎治疗市场：解剖结构、估计与趋势分析

  • 细分仪表板
  • 全球骨关节炎治疗市场波动分析
  • 2018-2030年全球骨关节炎治疗市场规模及趋势分析、解剖结构
  • 膝骨关节炎
  • 髋骨关节炎
  • 手骨关节炎
  • 其他的

第六章骨关节炎治疗市场：给药途径、估计与趋势分析

  • 细分仪表板
  • 全球骨关节炎治疗市场波动分析
  • 2018-2030 年全球骨关节炎治疗市场规模与趋势分析（依给药途径）
  • 肠外给药
  • 局部的
  • 口服给药

第七章骨关节炎治疗市场：按销售管道估计和趋势分析

  • 细分仪表板
  • 全球骨关节炎治疗市场波动分析
  • 2018-2030年全球骨关节炎治疗市场规模及趋势分析（依销售管道）
  • 联合用药
  • 非处方药

第八章骨关节炎治疗市场：最终用途的估计和趋势分析

  • 细分仪表板
  • 全球骨关节炎治疗市场波动分析
  • 2018-2030 年全球骨关节炎治疗市场规模与趋势分析（依最终用途）
  • 医院药房
  • 零售药房
  • 其他的

第九章骨关节炎治疗市场：按地区估计和趋势分析

  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第10章竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
    • 主要经销商及通路伙伴名单
    • 2024年主要企业市场占有率分析
    • Sanofi SA
    • GlaxoSmithKline plc
    • Pfizer Inc.
    • Bayer AG
    • Zimmer Biomet
    • Novartis AG
    • Anika Therapeutics
    • Assertio Therapeutics, Inc.
    • Bioventus
    • Ferring Pharmaceuticals Inc.
Product Code: GVR-4-68040-221-7

Osteoarthritis Therapeutics Market Growth & Trends:

The global osteoarthritis therapeutics market size is expected to reach USD 13.57 billion by 2030, registering a CAGR of 6.89% from 2025 to 2030, according to a new report by Grand View Research, Inc. The osteoarthritis therapeutics market is on the rise, driven by an increase in OA cases, especially among the aging population. In the U.S. alone, there are over 32.5 million OA patients, highlighting the demand for effective treatments. Ongoing research and development efforts are focused on creating new therapies, with a particular emphasis on understanding the disease and developing solutions to address its challenges.

Managing OA proves difficult owing to its dense tissue structure, but the introduction of novel drugs such as intra-articular drug administration has accelerated the development of targeted drug delivery. Researchers are actively exploring disease-modifying drugs and bioadaptive carriers to enhance the development of innovative osteoarthritis treatments. Market players are taking initiatives to contribute to market expansion, as seen with OrthoTrophix, Inc. presenting clinical data and a registration plan for TPX-100 for knee osteoarthritis at BIO 2022.

In addition, significant efforts are being made by key pharmaceutical companies and research institutes in realm of research and development, especially for disease-modifying osteoarthritis drugs. For instance, BioSenic's Phase 3 data presentation at the 2024 OARSI World Congress showcased the efficacy of JTA-004 in treating severe inflammatory knee osteoarthritis. The post hoc analysis concluded that JTA-004 is both safe and effective, offering targeted pain management for this specific subtype of condition. These advancements in targeted drug delivery and disease-modifying drugs, as demonstrated by presentations and positive trial results, are contributing to the expansion of the market for novel osteoarthritis treatments.

Moreover, the market for OA is experiencing significant growth owing to the introduction of personalized medications such as Bisphosphonates (anti-resorptive drugs) and Synvisc-ONE injection. In addition, pharmaceutical companies and research institutions are actively engaged in developing personalized treatments and cell-based therapies for OA. In December 2023, researchers at Columbia University made a breakthrough discovery of stem cells in adult mice capable of maintaining healthy cartilage in joints, with their decline contributing to OA development due to aging and injury.

Investing in this sector offers companies the opportunity to capitalize on evolving demands, thus gaining a competitive advantage. By leading innovative medication development, companies establish themselves as frontrunners, solidifying their position in the market. The advent of personalized OA medications and advancements in cell-based therapies are key drivers of market expansion, empowering companies to emerge as leaders in the field.

Osteoarthritis Therapeutics Market Report Highlights:

  • Based on drug type, the viscosupplementation agents segment accounted for the largest share of 37.06% in 2024 and is expected to grow at the fastest CAGR over the forecast period due to their adoption and efficacy in managing OA symptoms.
  • Based on anatomy, the knee osteoarthritis (KOA) segment held a dominant share of 42.07% in 2024. KOA is one of the most common forms of chronic articular disease and OA worldwide and is characterized by high disability & morbidity rates.
  • Based on route of administration, the parenteral route segment held a dominant share in 2024 and is expected to grow at a CAGR of 7.57% over the forecast period due to its efficacy for certain therapies, better pharmacokinetics and pharmacodynamics, ease of administration, and higher projected growth rate.
  • Prescription drugs are poised to maintain dominance in the osteoarthritis therapeutics market' sales Channel segment in 2024.
  • Based on end-use, the hospital pharmacies segment held a dominant share in 2024, accounting for 47.50%.
  • North America osteoarthritis therapeutics market dominated the global industry and accounted for a 37.31% share in 2024. The North American market maintains its dominance due to several factors, including a high prevalence of obesity and supportive government policies.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Drug Type
    • 1.2.2. Anatomy
    • 1.2.3. Route of Administration
    • 1.2.4. Sales Channel
    • 1.2.5. End Use
    • 1.2.6. Regional scope
    • 1.2.7. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Drug type outlook
    • 2.2.2. Anatomy outlook
    • 2.2.3. Route of administration outlook
    • 2.2.4. Sales channel outlook
    • 2.2.5. End use outlook
    • 2.2.6. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Osteoarthritis Therapeutics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. High Prevalence of Osteoarthritis
      • 3.2.1.2. Growing Aging Population
      • 3.2.1.3. Technological Advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Side Effects and Adverse Reactions
      • 3.2.2.2. High cost of osteoarthritis therapeutics drugs
  • 3.3. Osteoarthritis Therapeutics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pricing Analysis

Chapter 4. Osteoarthritis Therapeutics Market: Drug Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Osteoarthritis Therapeutics Market by Drug Type Outlook
  • 4.3. Global Osteoarthritis Therapeutics Market Size & Trend Analysis, by Drug Type, 2018 to 2030 (USD Million)
  • 4.4. Viscosupplementation Agents
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Nonsteroidal Anti-inflammatory Drugs
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.1.1. Naproxen
        • 4.5.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.1.2. Aspirin
        • 4.5.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.1.3. Diclofenac
        • 4.5.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.1.4. Ibuprofen
        • 4.5.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.1.5. Celecoxib
        • 4.5.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.1.6. Meloxicam
        • 4.5.1.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.1.7. Piroxicam
        • 4.5.1.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.1.8. Ketoprofen
        • 4.5.1.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.1.9. Other NSAIDs
        • 4.5.1.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Analgesics
      • 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
        • 4.5.2.1.1. Duloxetine
          • 4.5.2.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
        • 4.5.2.1.2. Acetaminophen
          • 4.5.2.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Corticosteroids
      • 4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.4. Others
      • 4.5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Osteoarthritis Therapeutics Market: Anatomy Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Osteoarthritis Therapeutics Market Movement Analysis
  • 5.3. Global Osteoarthritis Therapeutics Market Size & Trend Analysis, by Anatomy, 2018 to 2030 (USD Million)
  • 5.4. Knee Osteoarthritis
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Hip Osteoarthritis
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Hand Osteoarthritis
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Osteoarthritis Therapeutics Market: Route of Administration Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Osteoarthritis Therapeutics Market Movement Analysis
  • 6.3. Global Osteoarthritis Therapeutics Market Size & Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
  • 6.4. Parenteral Route
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.1.1. Hyaluronic Acid Injections
        • 6.4.1.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.1.2. Corticosteroid Injections
        • 6.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.1.3. Platelet-rich Plasma (PRP) Injections
        • 6.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.1.4. Placental Tissue Matrix (PTM) Injections
        • 6.4.1.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.1.5. Acetylsalicylic Acid (ASA) Injections
        • 6.4.1.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 6.4.1.6. Others
        • 6.4.1.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Topical Route
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Oral Route
    • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Osteoarthritis Therapeutics Market: Sales Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Osteoarthritis Therapeutics Market Movement Analysis
  • 7.3. Global Osteoarthritis Therapeutics Market Size & Trend Analysis, by Sales Channel, 2018 to 2030 (USD Million)
  • 7.4. Prescription Drugs
    • 7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Over-the-Counter Drugs
    • 7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Osteoarthritis Therapeutics Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. Global Osteoarthritis Therapeutics Market Movement Analysis
  • 8.3. Global Osteoarthritis Therapeutics Market Size & Trend Analysis, by End Use 2018 to 2030 (USD Million)
  • 8.4. Hospital Pharmacies
    • 8.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Retail Pharmacies
    • 8.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Others
    • 8.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Osteoarthritis Therapeutics Market: Regional Estimates & Trend Analysis by

  • 9.1. Regional Market Dashboard
  • 9.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 9.3. North America
    • 9.3.1. U.S.
      • 9.3.1.1. Key country dynamics
      • 9.3.1.2. Regulatory framework/ reimbursement structure
      • 9.3.1.3. Competitive scenario
      • 9.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.2. Canada
      • 9.3.2.1. Key country dynamics
      • 9.3.2.2. Regulatory framework/ reimbursement structure
      • 9.3.2.3. Competitive scenario
      • 9.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.3.3. Mexico
      • 9.3.3.1. Key country dynamics
      • 9.3.3.2. Regulatory framework/ reimbursement structure
      • 9.3.3.3. Competitive scenario
      • 9.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4. Europe
    • 9.4.1. UK
      • 9.4.1.1. Key country dynamics
      • 9.4.1.2. Regulatory framework/ reimbursement structure
      • 9.4.1.3. Competitive scenario
      • 9.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.2. Germany
      • 9.4.2.1. Key country dynamics
      • 9.4.2.2. Regulatory framework/ reimbursement structure
      • 9.4.2.3. Competitive scenario
      • 9.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.3. France
      • 9.4.3.1. Key country dynamics
      • 9.4.3.2. Regulatory framework/ reimbursement structure
      • 9.4.3.3. Competitive scenario
      • 9.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.4. Italy
      • 9.4.4.1. Key country dynamics
      • 9.4.4.2. Regulatory framework/ reimbursement structure
      • 9.4.4.3. Competitive scenario
      • 9.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.5. Spain
      • 9.4.5.1. Key country dynamics
      • 9.4.5.2. Regulatory framework/ reimbursement structure
      • 9.4.5.3. Competitive scenario
      • 9.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.6. Norway
      • 9.4.6.1. Key country dynamics
      • 9.4.6.2. Regulatory framework/ reimbursement structure
      • 9.4.6.3. Competitive scenario
      • 9.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.7. Sweden
      • 9.4.7.1. Key country dynamics
      • 9.4.7.2. Regulatory framework/ reimbursement structure
      • 9.4.7.3. Competitive scenario
      • 9.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.4.8. Denmark
      • 9.4.8.1. Key country dynamics
      • 9.4.8.2. Regulatory framework/ reimbursement structure
      • 9.4.8.3. Competitive scenario
      • 9.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Japan
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework/ reimbursement structure
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.2. China
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework/ reimbursement structure
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.3. India
      • 9.5.3.1. Key country dynamics
      • 9.5.3.2. Regulatory framework/ reimbursement structure
      • 9.5.3.3. Competitive scenario
      • 9.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.4. Australia
      • 9.5.4.1. Key country dynamics
      • 9.5.4.2. Regulatory framework/ reimbursement structure
      • 9.5.4.3. Competitive scenario
      • 9.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.5. South Korea
      • 9.5.5.1. Key country dynamics
      • 9.5.5.2. Regulatory framework/ reimbursement structure
      • 9.5.5.3. Competitive scenario
      • 9.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.6. Thailand
      • 9.5.6.1. Key country dynamics
      • 9.5.6.2. Regulatory framework/ reimbursement structure
      • 9.5.6.3. Competitive scenario
      • 9.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Brazil
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework/ reimbursement structure
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.2. Argentina
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework/ reimbursement structure
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7. MEA
    • 9.7.1. South Africa
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework/ reimbursement structure
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.2. Saudi Arabia
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework/ reimbursement structure
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.3. UAE
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework/ reimbursement structure
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.4. Kuwait
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework/ reimbursement structure
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
  • 10.3. Vendor Landscape
    • 10.3.1. List of key distributors and channel partners
    • 10.3.2. Key customers
    • 10.3.3. Key company market share analysis, 2024
    • 10.3.4. Sanofi SA
      • 10.3.4.1. Company overview
      • 10.3.4.2. Financial performance
      • 10.3.4.3. Product benchmarking
      • 10.3.4.4. Strategic initiatives
    • 10.3.5. GlaxoSmithKline plc
      • 10.3.5.1. Company overview
      • 10.3.5.2. Financial performance
      • 10.3.5.3. Product benchmarking
      • 10.3.5.4. Strategic initiatives
    • 10.3.6. Pfizer Inc.
      • 10.3.6.1. Company overview
      • 10.3.6.2. Financial performance
      • 10.3.6.3. Product benchmarking
      • 10.3.6.4. Strategic initiatives
    • 10.3.7. Bayer AG
      • 10.3.7.1. Company overview
      • 10.3.7.2. Financial performance
      • 10.3.7.3. Product benchmarking
      • 10.3.7.4. Strategic initiatives
    • 10.3.8. Zimmer Biomet
      • 10.3.8.1. Company overview
      • 10.3.8.2. Financial performance
      • 10.3.8.3. Product benchmarking
      • 10.3.8.4. Strategic initiatives
    • 10.3.9. Novartis AG
      • 10.3.9.1. Company overview
      • 10.3.9.2. Financial performance
      • 10.3.9.3. Product benchmarking
      • 10.3.9.4. Strategic initiatives
    • 10.3.10. Anika Therapeutics
      • 10.3.10.1. Company overview
      • 10.3.10.2. Financial performance
      • 10.3.10.3. Product benchmarking
      • 10.3.10.4. Strategic initiatives
    • 10.3.11. Assertio Therapeutics, Inc.
      • 10.3.11.1. Company overview
      • 10.3.11.2. Financial performance
      • 10.3.11.3. Product benchmarking
      • 10.3.11.4. Strategic initiatives
    • 10.3.12. Bioventus
      • 10.3.12.1. Company overview
      • 10.3.12.2. Financial performance
      • 10.3.12.3. Product benchmarking
      • 10.3.12.4. Strategic initiatives
    • 10.3.13. Ferring Pharmaceuticals Inc.
      • 10.3.13.1. Company overview
      • 10.3.13.2. Financial performance
      • 10.3.13.3. Product benchmarking
      • 10.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of key distributors and channel partners
  • Table 2 List of key emerging companies'/technology disruptors/innovators
  • Table 3 North America Osteoarthritis Therapeutics Market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 5 North America Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 6 North America Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 7 North America Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 8 North America Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 9 U.S. Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 10 U.S. Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 11 U.S. Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 12 U.S. Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 13 U.S. Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 14 Canada Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 15 Canada Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 16 Canada Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 17 Canada Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 18 Canada Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 19 Europe Osteoarthritis Therapeutics Market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 21 Europe Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 22 Europe Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 23 Europe Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 24 Europe Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Germany Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 26 Germany Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 27 Germany Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 28 Germany Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 29 Germany Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 30 UK Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 31 UK Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 32 UK Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 33 UK Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 34 UK Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 35 France Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 36 France Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 37 France Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 38 France Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 39 France Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 40 Italy Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 41 Italy Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 42 Italy Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million
  • Table 43 Italy Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 44 Italy Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Spain Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 46 Spain Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 47 Spain Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 48 Spain Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 49 Sapin Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 50 Denmark Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 51 Denmark Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 52 Denmark Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 53 Denmark Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 54 Denmark Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 55 Sweden Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 56 Sweden Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 57 Sweden Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 58 Sweden Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 59 Sweden Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 60 Norway Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 61 Norway Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 62 Norway Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 63 Norway Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 64 Norway Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific Osteoarthritis Therapeutics Market, by country, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 67 Asia Pacific Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 68 Asia Pacific Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 69 Asia Pacific Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 70 Asia Pacific Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 71 Japan Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 72 Japan Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 73 Japan Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 74 Japan Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 75 Japan Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 76 China Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 77 China Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 78 China Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 79 China Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 80 China Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 81 India Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 82 India Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 83 India Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 84 India Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 85 India Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 86 Australia Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 87 Australia Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 88 Australia Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 89 Australia Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 90 Australia Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 91 South Korea Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 92 South Korea Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 93 South Korea Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 94 South Korea Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 95 South Korea Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 96 Thailand Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 97 Thailand Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 98 Thailand Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 99 Thailand Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 100 Thailand Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 101 Latin America Osteoarthritis Therapeutics Market, by country, 2018 - 2030 (USD Million)
  • Table 102 Latin America Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 103 Latin America Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 104 Latin America Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million
  • Table 105 Latin America Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 106 Latin America Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 107 Brazil Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 108 Brazil Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 109 Brazil Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 110 Brazil Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 111 Brazil Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 112 Mexico Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 113 Mexico Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 114 Mexico Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 115 Mexico Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 116 Mexico Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 117 Argentina Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 118 Argentina Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 119 Argentina Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 120 Argentina Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 121 Argentina Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 122 MEA Osteoarthritis Therapeutics Market, by country, 2018 - 2030 (USD Million)
  • Table 123 MEA Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 124 MEA Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 125 MEA Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 126 MEA Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 127 MEA Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 128 South Africa Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 129 South Africa Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 130 South Africa Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 131 South Africa Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 132 South Africa Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 133 Saudi Arabia Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 134 Saudi Arabia Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 135 Saudi Arabia Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 136 Saudi Arabia Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 137 Saudi Arabia Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 138 UAE Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 139 UAE Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 140 UAE Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 141 UAE Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 142 UAE Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Table 143 Kuwait Osteoarthritis Therapeutics Market, by Drug Type, 2018 - 2030 (USD Million)
  • Table 144 Kuwait Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Table 145 Kuwait Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 146 Kuwait Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Table 147 Kuwait Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Osteoarthritis Therapeutics Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Osteoarthritis Therapeutics Market snapshot (2024)
  • Fig. 9 Osteoarthritis Therapeutics Market: Segment snapshot (2024)
  • Fig. 10 Competitive Insights (2024)
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Osteoarthritis Therapeutics Market driver impact
  • Fig. 15 Osteoarthritis Therapeutics Market restraint impact
  • Fig. 16 Clinical chemistry industry challenges
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 SWOT Analysis, By Factor (Political & legal Economic and technological)
  • Fig. 19 Strategic alliance analysis
  • Fig. 20 Recent developments & impact analysis, by key market participants
  • Fig. 21 Key company market share analysis, 2024
  • Fig. 22 Company market position analysis
  • Fig. 23 Definition and scope, by drug type
  • Fig. 24 Drug type market share analysis, 2024 & 2030
  • Fig. 25 Segment dashboard
  • Fig. 26 Global Osteoarthritis Therapeutics Market, by drug type, 2018 - 2030 (USD Million)
  • Fig. 27 Viscosupplementation Agents market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 28 Nonsteroidal Anti-inflammatory Drugs market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 29 Naproxen market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 30 Aspirin market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 31 Diclofenac market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 32 Ibuprofen market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 33 Celecoxib market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 34 Meloxicam market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 35 Piroxicam market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 36 Ketoprofen market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 37 Other NSAIDs market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 38 Analgesics market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 39 Duloxetine market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 40 Acetaminophen market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 41 Corticosteroids market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 42 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 43 Definition and scope, by Anatomy
  • Fig. 44 Anatomy market share analysis, 2024 & 2030
  • Fig. 45 Segment dashboard
  • Fig. 46 Global Osteoarthritis Therapeutics Market, by Anatomy, 2018 - 2030 (USD Million)
  • Fig. 47 Knee Osteoarthritis market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 48 Hip Osteoarthritis market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 49 Hand Osteoarthritis market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 50 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 51 Definition and scope, by Route of Administration
  • Fig. 52 Anatomy market share analysis, 2024 & 2030
  • Fig. 53 Segment dashboard
  • Fig. 54 Global Osteoarthritis Therapeutics Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Fig. 55 Parenteral route market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 56 Hyaluronic acid injections market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 57 Corticosteroid Injections market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 58 Platelet-rich Plasma (PRP) Injections market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 59 Placental Tissue Matrix (PTM) Injections market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 60 Acetylsalicylic Acid (ASA) Injections market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 61 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 62 Topical Route market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 63 Oral route market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 64 Definition and scope, by Sales Channel
  • Fig. 65 Sales Channel market share analysis, 2024 & 2030
  • Fig. 66 Segment dashboard
  • Fig. 67 Global Osteoarthritis Therapeutics Market, by Sales Channel, 2018 - 2030 (USD Million)
  • Fig. 68 Prescription Drugs market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 69 Over-the-Counter drugs market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 70 Definition and scope, by End Use
  • Fig. 71 End Use market share analysis, 2024 & 2030
  • Fig. 72 Segment dashboard
  • Fig. 73 Global Osteoarthritis Therapeutics Market, by End Use, 2018 - 2030 (USD Million)
  • Fig. 74 Hospital Pharmacies market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 75 Retail Pharmacies market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 76 Others market size & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 77 North America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 78 U.S. market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 79 Canada market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 80 Europe market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 81 UK market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 82 Germany market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 83 Spain market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 84 France market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 85 Italy market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 86 Sweden market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 87 Denmark market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 88 Norway market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 89 Asia Pacific market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 90 China market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 91 Japan market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 92 India market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 93 Australia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 94 South Korea market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 95 Thailand market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 96 Latin America market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 97 Brazil market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 98 Mexico market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 99 Argentina market size, & forecasts and trend analysis, 2018 to 2030 (USD Million))
  • Fig. 100 Middle East and Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 101 South Africa market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 102 Saudi Arabia market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 103 UAE market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)
  • Fig. 104 Kuwait market size, & forecasts and trend analysis, 2018 to 2030 (USD Million)